As of May 2024 Arrowhead Pharmaceuticals has a market cap of $3.09 Billion. This makes Arrowhead Pharmaceuticals the world's 3466th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $3.09 B | -6% |
2023 | $3.28 B | -28.79% |
2022 | $4.61 B | -33.39% |
2021 | $6.93 B | -12.11% |
2020 | $7.88 B | 22.94% |
2019 | $6.41 B | 457.7% |
2018 | $1.14 B | 317.62% |
2017 | $0.27 B | 139.52% |
2016 | $0.11 B | -68.65% |
2015 | $0.36 B | -9.19% |
2014 | $0.40 B | -4.58% |
2013 | $0.42 B | 1164.02% |
2012 | $33.47 M | -24.09% |
2011 | $44.1 M | -31.37% |
2010 | $64.26 M | 93.12% |
2009 | $33.27 M | -15.75% |
2008 | $39.49 M | -73.01% |
2007 | $0.14 B | -2.4% |
2006 | $0.14 B | 5.07% |
2005 | $0.14 B | 134.03% |
2004 | $60.97 M | 57631.68% |
2003 | $0.1 M | 233.72% |
2002 | $0.03 M | -60% |
2001 | $0.07 M |
On May 14th, 2024 the market cap of Arrowhead Pharmaceuticals was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $365.05 B | 11,713.86% | ๐บ๐ธ USA |
Moderna
MRNA | $48.11 B | 1,456.97% | ๐บ๐ธ USA |
Ligand Pharmaceuticals LGND | $1.55 B | -49.74% | ๐บ๐ธ USA |
Dicerna Pharmaceuticals DRNA | $2.97 B | -3.64% | ๐บ๐ธ USA |
Alnylam Pharmaceuticals
ALNY | $19.02 B | 515.68% | ๐บ๐ธ USA |
Inovio Pharmaceuticals INO | $0.31 B | -89.91% | ๐บ๐ธ USA |